Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Devillier

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamideR Crocchiolo, L Castagna, S Furst, et al.
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation|May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphomaL Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation|March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamideR Crocchiolo, L Castagna, S Furst, et al.
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Pageof 2